Search

AURA 2021 is the fourth in a series of national reports on the critical issues of antimicrobial resistance (AMR), and the use of antimicrobials (AU), in Australia.

The focus of Chapter 5 is CARAlert, the National Alert System for Critical Antimicrobial Resistances in Australia; this resource providing figures and tables for use in presentations and other documents, to allow ease of access to data at the local and jurisdiction levels. 

AURA 2021 is the fourth in a series of national reports on the critical issues of antimicrobial resistance (AMR), and the use of antimicrobials (AU) in Australia. The focus of Chapter 4 is AMR in Australia, with this resource providing figures and tables for use in presentations and other documents, to allow ease of access to data at the local level, and for all jurisdictions. 

AURA 2021 is the fourth in a series of national reports on the critical issues of antimicrobial resistance (AMR), and the use of antimicrobials (AU), in Australia.

The focus of Chapter 3 is antimicrobial use and the appropriateness of use in Australia; this resource provides figures and tables for use in presentations and other documents, to allow ease of access to data at the local level, and for all jurisdictions. 

The Consumer Summary provides an overview of the key findings and messages of AURA 2021 for consumers.

This resource provides a summary of some of the key data from AURA 2021 that may be of specific interest to public health professionals.

This resource provides a summary of AURA 2021 data that may be of specific interest to members of infection prevention and control teams.

This resource provides a summary of AURA 2021 data that may be of specific interest to medical practitioners.

This resource provides a summary of AURA 2021 data that may be of specific interest to hospital and community pharmacists.

This report provides supplementary data relevant to Chapter 4 of AURA 2021 - Antimicrobial resistance.

This report includes analyses of antimicrobial resistance and antimicrobial use data predominantly collected in 2018 and 2019, and 2020 data from the National Alert System for Critical Antimicrobial Resistances (CARAlert) the Pharmaceutical Benefits Scheme (PBS) in the context of the COVID-19 pandemic.

This latest CARAlert Data Update includes data submitted to CARAlert between 1 March 2021 and 30 April 2021. This update provides useful information to support prevention and containment of antimicrobial resistance.

Chapter 16 of the AMS Book highlights issues related to antimicrobial use in the community and in residential aged care and describes infections experienced by older people and strategies to improve antimicrobial prescribing and use. 

This factsheet highlights the issues surrounding antimicrobial use in older people and provides information for older people, their families and their carers.